XML 105 R101.htm IDEA: XBRL DOCUMENT v3.20.1
Commitments and Contingencies - Additional Information (Detail)
€ in Millions
12 Months Ended
Dec. 30, 2016
shares
Dec. 30, 2016
EUR (€)
May 12, 2016
Sep. 21, 2015
shares
Jun. 12, 2014
Nov. 02, 2009
Dec. 31, 2019
USD ($)
Dec. 31, 2018
USD ($)
Jan. 08, 2018
Dec. 31, 2017
USD ($)
Oct. 25, 2013
Operating Leased Assets [Line Items]                      
Fair value of contingent consideration             $ 1,084,000 $ 10,637,000      
Liability or related charge recorded for legal contingencies             0        
Operating leases, rent expense               1,200,000      
Corporate offices                      
Operating Leased Assets [Line Items]                      
Operating lease, lease not yet commenced           5 years          
Operating lease, renew option period         3 years            
Operating lease, lease not yet commenced, term of contract                 18 months    
Operating lease agreement period           5 years          
Warehouse                      
Operating Leased Assets [Line Items]                      
Operating lease additional renewed period                     6 years
Operating leases, rent expense             1,400,000 1,200,000      
Senhance Surgical Robotic System Acquisition                      
Operating Leased Assets [Line Items]                      
Fair value of contingent consideration             10,600,000        
Common shares issued | shares       1,195,647              
Senhance Surgical Robotic System Acquisition | License and Supply Agreements                      
Operating Leased Assets [Line Items]                      
Commitments under agreements, in 2020             5,500,000        
Commitments under agreements, in 2021             600,000        
Commitments under agreements, in 2022             600,000        
Commitments under agreements, in 2023             600,000        
Commitments under agreements, in 2024             600,000        
Commitments until termination in 2027             1,100,000        
Senhance Surgical Robotic System Acquisition | Second Tranche                      
Operating Leased Assets [Line Items]                      
Fair value of contingent consideration | €   € 5.0                  
Common shares issued | shares 286,360                    
Contingent consideration related to acquisition | €   € 5.0                  
TransEnterix Italia | Research and Development and Demonstration Facilities                      
Operating Leased Assets [Line Items]                      
Operating lease agreement period     6 years                
Level 3                      
Operating Leased Assets [Line Items]                      
Fair value of contingent consideration             1,084,000 10,637,000      
Contingent Consideration                      
Operating Leased Assets [Line Items]                      
Fair value, contingent consideration             $ 1,084,000 $ 10,637,000   $ 12,418,000